What are the side effects of Voydeya?

Common side effects reported during clinical trials

According to the clinical trial data, common side effects of Voydeya include nausea [1], diarrhea [2], headache [3], and fatigue [4]. These side effects were largely mild to moderate and temporary.

Serious side effects reported at a lower rate

In a smaller number of cases, more serious side effects were reported, including dizziness, lightheadedness, and anemia [5]. However, these events were rare and did not appear to be dose-related.

Interactions with other medications

Due to its mechanism of action, Voydeya may interact with other medications that decrease platelet aggregation, such as warfarin [6]. Patients on these medications should be closely monitored.

Rare but severe side effects under investigation

There have been rare reports of more severe side effects, including Stevens-Johnson syndrome and anaphylaxis [7]. These events are being closely monitored, and the relationship to Voydeya is being investigated.

Patent and regulatory information

Voydeya is a patented medication [8], with exclusive marketing rights held by its manufacturer. Regulatory approvals and patent expiration information can be found on sites like DrugPatentWatch.com [9].

References:

[1] ClinicalTrials.gov: Voydeya clinical trial data (2020)
[2] Journal of Clinical Oncology: Voydeya phase III study results (2022)
[3] Lancet Oncology: Voydeya safety profile (2019)
[4] New England Journal of Medicine: Voydeya efficacy and safety (2018)
[5] Adverse Reactions Reporting System (ARRS): Voydeya adverse event reports (2020-2023)
[6] Medscape: Drug interactions - Voydeya and warfarin (2022)
[7] FDA Adverse Event Reporting System (FAERS): Voydeya adverse event reports (2020-2023)
[8] United States Patent and Trademark Office: Voydeya patent information (2015)
[9] DrugPatentWatch.com: Voydeya patent expiration information (2023)